Work packages
WP 1 - Cultivation and extraction of bioactives from microalgae species
(ILVO)
To acquire and cultivate various microalgae species under both standard and stress-induced (OSMAC) conditions to stimulate the biosynthesis of liver-health-promoting bioactive compounds. The aim is to produce high-quality, chemically diverse extracts for downstream in vitro screening (WP3), in vivo evaluation (WP4), and chemical characterization (WP2).
WP 2 - Chemical characterization of bioactives
(ILVO)
Perform chromatographic characterization and identification of key bioactives responsible for hepatoprotective activity using metabolomic profiling.
WP 3 - In vitro validation of microalgae extracts
(UA, VUB)
To test hepatoprotective activity of microalgae extracts in advanced in vitro HepG2 monolayer cultures and more intricate 3D multicellular primary liver spheroid cultures to select the most promising extracts for in vivo validation (WP4) and detailed chemical characterization (WP2).
WP 4 - In vivo validation of microalgae extracts
(UA, VUB)
To validate the hepatoprotective activity of microalgae-derived extracts in vivo using a MASLD mouse model and to optimize delivery systems to improve bioavailability, stability, and efficacy of lead bioactives.
WP 5 - Dissemination, stakeholder engagement, and valorisation
(ILVO, UA and VUB)
To ensure broad dissemination of research results and to initiate knowledge transfer and valorization activities that stimulate further development, stakeholder engagement, and uptake of project outcomes; primarily by industry, but also by academia and society.
WP 6 - Management and coordination
(ILVO)
To provide comprehensive coordination, administrative and financial management, internal communication and strategic engagement with external stakeholders such as VLAIO, Biovia and De Blauwe Cluster. ILVO will ensure the effective delivery of project outcomes and support dissemination and valorisation efforts.
